Condition: Valvular Heart Disease Stenosis and Regurgitation · Valvular Heart Disease · Sponsor: I.M. Sechenov First Moscow State Medical University
It is a prospective, controlled, single-center, observational, non-randomized study. The study is planned to include at least 1000 patients over 18 years old in the training sample and 200 patients over 18 years old in the test sample (the total number of patients is at least 1200 people). All patients will undergo an echocardiography examination with a comprehensive analysis of the function of the valves and other structures of the heart according to current recommendations by two independent experts. Registration of electrocardiogram will be performed immediately after echocardiography using a single lead ECG monitor (in I standard lead) for 1 minutes. The obtained data will be stored in the remote monitoring center of Sechenov University without being linked to the personal data of patients. A spectral analysis of the electrocardiogram will be performed using a continuous wavelet transform. The result of this study will be the identification of ECG parameters that will correlate with valvular heart disease.
This description comes directly from the study's public registry record.
Natalia Kuznetsova, Dr. · +79164778724 · kuznetsova_n_o@staff.sechenov.ru
Petr Chomakhidze, Prof. · +79166740369 · chomakhidze_p_sh@staff.sechenov.ru
Always discuss trial participation with your own doctor first.
| I.M. Sechenov First Moscow State Medical University (Sechenov University) | Moscow, Russia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07099417